Ligand validation:6F9R

D0W: Sampatrilat-Asp

D0W is a Ligand Of Interest in 6F9R designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6F9R_D0W_A_710	78%	18%	0.112	0.956	2.19	1.35	7	6	2	0	100%	1
6F9R_D0W_B_711	63%	19%	0.131	0.926	2.26	1.23	7	4	2	0	100%	1
6F9U_D0W_A_711	63%	15%	0.148	0.942	2.34	1.44	8	6	2	0	100%	1
6SVY_D0W_A_802	54%	18%	0.175	0.942	2.42	1.15	9	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.